Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
The chart shows the growth of an initial investment of $10,000 in Sabra Healthcare REIT, Inc., comparing it to the performance of the S&P 500 index. All prices have been adjusted for splits and dividends.
Returns By Period
Sabra Healthcare REIT, Inc. (SBRA) has returned 5.30% so far this year and 18.85% over the past 12 months. Looking at the last ten years, SBRA has achieved an annualized return of -0.03%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
SBRA
1M-1.39%
6M9.48%
YTD5.30%
1Y18.85%
5Y1.95%
10Y-0.03%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of Sabra Healthcare REIT, Inc. (SBRA) with color gradation from worst to best to easily spot seasonal factors.
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2026
-0.69%
9.08%
-6.42%
3.28%
2025
-3.35%
0.54%
5.81%
1.77%
-1.80%
6.28%
-2.33%
4.20%
-2.00%
-3.73%
10.29%
-2.42%
2024
-6.06%
4.13%
6.64%
-6.07%
4.89%
5.77%
5.87%
4.67%
9.21%
3.36%
-5.31%
-7.28%
2023
6.89%
-11.84%
-2.95%
-1.04%
-1.05%
3.79%
10.37%
-3.32%
10.37%
-1.87%
7.04%
-1.92%
2022
-0.59%
11.45%
-21.56%
18.48%
-0.78%
11.12%
-3.42%
-11.59%
3.64%
-5.63%
-4.38%
2021
-3.89%
1.83%
-1.31%
4.01%
-4.43%
3.88%
1.64%
-14.16%
-8.63%
-5.10%
-8.94%
3.20%
2020
0.28%
-9.53%
-44.62%
24.35%
9.52%
7.45%
2.36%
0.47%
-6.29%
-5.12%
24.00%
3.58%
2019
25.86%
-12.17%
6.86%
-0.36%
-1.63%
1.65%
4.19%
3.49%
5.76%
7.14%
-9.39%
-4.09%
2018
-3.42%
-6.74%
4.13%
3.74%
13.03%
4.42%
3.25%
9.17%
-1.87%
-6.60%
-11.31%
-14.83%
2017
3.72%
7.55%
2.08%
-2.58%
-14.33%
2.90%
-4.33%
-6.10%
0.27%
-9.45%
-3.22%
-2.80%
2016
5.93%
-1.46%
-2.94%
15.34%
6.61%
-1.33%
-7.13%
-4.32%
11.00%
Performance Indicators
The charts below present risk-adjusted performance metrics for Sabra Healthcare REIT, Inc. (SBRA) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of SBRA compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current Sabra Healthcare REIT, Inc. volatility is 1.28%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses. Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Liabilities And Equity (USD)
5.49B
5.39B
5.75B
5.97B
5.99B
6.07B
6.67B
7.03B
2.27B
2.49B
2.06B
1.20B
916.88M
749.65M
Equity Attributable To Parent (USD)
2.82B
2.80B
3.06B
3.38B
3.41B
3.49B
3.25B
3.43B
1.02B
1.05B
941.87M
460.16M
305.49M
326.57M
Equity Attributable To Noncontrolling Interest (USD)
Engineers Gate Manager LP reduced its position in Sabra Health Care REIT by 1,513,777 shares (valued at ~$28.06 million), bringing the stake to 1.02% of the fund's assets. The sale reflects investor focus on healthcare REIT rental income sustainability, particularly as operators face challenges from Medicare/Medicaid reimbursement, labor costs, and occupancy trends.
The Motley Fool•Eric Trie
AI Insight
The position reduction by a major investor suggests caution, but the article frames this as part of normal portfolio management rather than a fundamental concern. The company maintains a solid dividend yield (5.87%) and large property portfolio, though investors are monitoring operator health and rent collection trends amid industry headwinds.
Engineers Gate Manager LP increased its stake in Agree Realty (ADC) by 1,144,617 shares, bringing its total position to $85.16 million. The investment represents 1.01% of the fund's assets under management. ADC shares have appreciated 13.4% over the past year, outperforming the S&P 500.
The Motley Fool•Eric Trie
AI Insight
Listed as Engineers Gate's fourth-largest holding but not discussed in the article.
Sabra Health Care REIT exceeded Q2 2025 analyst expectations with strong performance in managed senior housing, reporting normalized FFO of $0.37 per share and revenue of $189.15 million, representing a 7.4% year-over-year increase.
The Motley Fool•Jesterai
AI Insight
Outperformed analyst estimates, showed 17.1% year-over-year increase in same-store managed senior housing Cash NOI, closed $122.3 million in new senior housing investments, maintained dividend, and improved net debt to adjusted EBITDA ratio
The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Evaluate the expected performance of Sabra (SBRA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said if you are looking for a stock that’s on the verge of breaking out, Deere & Company (NYSE: DE).
On March 25, Deere & Company said former Eastman Chemical Company executive, Kellye Walker, will join its leadership team as senior vice president, chief legal officer and worldwide public affairs, effective April 29.
Stephen Weiss of Short Hills Capital Partners picked ASML Holding N.V. (NASDAQ: ASML), saying that ...
The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sabra (SBRA) delivered FFO and revenue surprises of -2.94% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Beyond analysts' top -and-bottom-line estimates for Sabra (SBRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.